160 related articles for article (PubMed ID: 32723257)
1. In Vivo Biological Evaluation of Ethyl 4-(7-hydroxy-4-methyl-2-oxoquinolin-1- ylamino)-coumarin-3-carboxylate as an Antitumor Agent.
Mohammed FZ; Rizzk YW; Abdelhamid MS; El-Deen IM
Anticancer Agents Med Chem; 2020; 20(18):2246-2266. PubMed ID: 32723257
[TBL] [Abstract][Full Text] [Related]
2. Molecular Docking and In Vivo Biological Studies of Sodium Salt of 3-(4-Methyl-2-oxo-2-H-quinoline-7-yloxy)-3-phenylacrylic Acid As Anticancer Agent.
Mohamed FZ; Eid SA; Elghareb MS; Abas AM
Dokl Biochem Biophys; 2023 Oct; 512(1):300-318. PubMed ID: 38093135
[TBL] [Abstract][Full Text] [Related]
3. C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice.
Bevara GB; Kumar ADN; Koteswramma K L; Badana AK; Kumari S; Yarla NS; Malla RR
Anticancer Agents Med Chem; 2017; 17(9):1256-1266. PubMed ID: 28044935
[TBL] [Abstract][Full Text] [Related]
4. In vivo biological evaluation of sodium salt of ethyl (E)-2-cyano-3-(7-hydroxy-4-methyl-2-oxoquinoline-1(2H)-yl)-3-(4-hydroxyphenyl) acrylate as anticancer agent.
Mohammed FZ; Abd El-Aziz RM; El-Deen IM; Abd-Rahman MS; AlGhannam SM
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):145-174. PubMed ID: 34536310
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of new curcumin analogues as antioxidant and antitumor agents: molecular modeling study.
Bayomi SM; El-Kashef HA; El-Ashmawy MB; Nasr MN; El-Sherbeny MA; Abdel-Aziz NI; El-Sayed MA; Suddek GM; El-Messery SM; Ghaly MA
Eur J Med Chem; 2015 Aug; 101():584-94. PubMed ID: 26197162
[TBL] [Abstract][Full Text] [Related]
6. Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice.
Bhowmik T; Saha PP; DasGupta AK; Gomes A
Curr Drug Deliv; 2014; 11(5):652-64. PubMed ID: 24827982
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
8. Bioactive component, cantharidin from Mylabris cichorii and its antitumor activity against Ehrlich ascites carcinoma.
Verma AK; Prasad SB
Cell Biol Toxicol; 2012 Jun; 28(3):133-47. PubMed ID: 22402807
[TBL] [Abstract][Full Text] [Related]
9. Trehalose enhances the antitumor potential of methotrexate against mice bearing Ehrlich ascites carcinoma.
El-Magd MA; Khamis A; Nasr Eldeen SK; Ibrahim WM; Salama AF
Biomed Pharmacother; 2017 Aug; 92():870-878. PubMed ID: 28599251
[TBL] [Abstract][Full Text] [Related]
10. Antitumor Potential of Berberine and Cinnamic Acid against Solid Ehrlich Carcinoma in Mice.
Almeer RS; Aref AM; Hussein RA; Othman MS; Abdel Moneim AE
Anticancer Agents Med Chem; 2019; 19(3):356-364. PubMed ID: 30451117
[TBL] [Abstract][Full Text] [Related]
11. Effect of Au-dextran NPs as anti-tumor agent against EAC and solid tumor in mice by biochemical evaluations and histopathological investigations.
Medhat D; Hussein J; El-Naggar ME; Attia MF; Anwar M; Latif YA; Booles HF; Morsy S; Farrag AR; Khalil WKB; El-Khayat Z
Biomed Pharmacother; 2017 Jul; 91():1006-1016. PubMed ID: 28525943
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antioxidant, anti-inflammatory, anticancer activities and molecular docking of Moringa oleifera seed oil extract against experimental model of Ehrlich ascites carcinoma in Swiss female albino mice.
Aldayel TS; Gad El Hak HN; Nafie MS; Saad R; Abdelrazek HMA; Kilany OE
BMC Complement Med Ther; 2023 Dec; 23(1):457. PubMed ID: 38098043
[TBL] [Abstract][Full Text] [Related]
13. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
14. A Newly Synthesized Derivative and a Natural Parent Molecule: Which Would Be More Beneficial as a Future Antitumor Candidate? Docking and In Vivo Study.
Saad EA; Zahran F; El-Ablack FZ; Eleneen AMA
Appl Biochem Biotechnol; 2022 Nov; 194(11):5386-5402. PubMed ID: 35779177
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Iron Oxide Nanoparticles of
Moustafa AMY; Abd El-Hamid El-Damrany MM; Youssef MM
Anticancer Agents Med Chem; 2023; 23(14):1652-1669. PubMed ID: 37198986
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic potential of novel non-toxic nucleoside analogues on EAC ascitic tumour cells.
Barua A; Choudhury P; Maity JK; Mandal SB; Mandal S; Saha P
Free Radic Res; 2019 Jan; 53(1):57-67. PubMed ID: 30624093
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.
Gardouh AR; Barakat BM; Qushawy MKE; El-Kazzaz AY; Sami MM; Zaitone SA
Chem Biol Interact; 2018 Nov; 295():52-63. PubMed ID: 29678497
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
19. Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer.
Nafie MS; Arafa K; Sedky NK; Alakhdar AA; Arafa RK
Chem Biol Interact; 2020 Jun; 324():109087. PubMed ID: 32294457
[TBL] [Abstract][Full Text] [Related]
20. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
El-Dayem SM; Fouda FM; Ali EH; Motelp BA
Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
